Your search found 4 Results
[Contraceptive fact sheets. A tool for advisors in logistics] Fiches factuelles sur les contraceptifs. Un outil pour les conseillers en logistique.
Arlington, Virginia, JSI, Family Planning Logistics Management Project, 1998.  p. (USAID Contract No. CCP-C-00-95-00028-04)This guide lists the visual indicators of eventual quality problems, special considerations, donors, manufacturers, brands, shelf life, primary and secondary conditioning, units per shipping crate, and the dimensions and weights of boxes of the following contraceptive methods: condoms, oral contraceptive pills, IUDs, injectables, contraceptive implants, spermicides, and other vaginal barrier methods. These methods are presented in different categories according to donor: USAID, IPPF, or FNUAP. These data are provided as a tool to consultants in logistics. References are given for additional information on each method discussed.
[Workshop on quality assurance of salt iodinization programs, October 1996] Atelier en matiere d'assurance de la qualite des programmes d'iodation du sel, Octobre 1996.
[Arlington, Virginia], JSI, OMNI, 1997 May. , 37 p. (USAID Contract No. HRN-C-00-93-00025-08)Despite the considerable progress which has been achieved in establishing salt iodination programs with the goal of covering broader populations in more countries, salt produced for eventual human consumption tends to be either over- or underiodized. To resolve that problem, quality assurance systems need to be created and implemented to ensure that the iodized salt being produced and consumed meets certain key standards. This workshop grew out of the ideas and efforts of salt producers, governmental decision-makers, and program and organization managers seeking to evaluate the essential elements of such quality assurance systems and to recommend which steps should be taken. The 27 workshop participants from several different fields and organizations therefore examined production problems, sales monitoring concerns at both the wholesale and retail levels, standards and their application, laboratory analyses, and policy development. Workshop participants came from South Africa, Bangladesh, Canada, Denmark, Eritrea, the US, Ghana, Guatemala, India, Pakistan, Holland, Philippines, Tanzania, and Thailand. Recommendations are presented.
A guide to sources of family planning program assistance. Guide des sources d'assistance dans le domaine dia planning familial.
Population Reports. Series J: Family Planning Programs. 1977 Mar; (15): p.This edition on Population Reports is intended to serve family planning administrators as a general guide to the major sources of assistance for ongoing program activities. Others seeking assistance for new programs may also find it useful. This guide also describes the major components of effective family planning services, indicates some of the sources that provide funds for each of them, and describes briefly the objectives and funding priorities of major assistance agencies. (excerpt)
Population Reports. Series A: Oral Contraceptives. 1974 Apr; (1): p.This report provides data on worldwide distribution of oral contraceptives (OCs) over the last decade. Marketing figures and information on government and international distribution programs were provided by AID, the Swedish International Development Authority, UNICEF, and IPPF. It is noted that in at least 5 developed countries (Canada, Australia, West Germany, the Netherlands, and New Zealand) 25% or more of all women aged 15-44 are regularly purchasing OCs from pharmacies. If women receiving supplies from family planning programs are included, the U.S. and the United Kingdom are now close to the 20% level. The highest usage rate is in the Netherlands where nearly 30% of the fecund women bought OCs regularly in 1972 and 37% in the first half of 1973. The hazards of OCs publicized in 1969 and 1970 caused noticeably reduced purchases. In Australia 15-22% of the women taking OCs discontinued their use following adverse reports. By 1971 when further evaluations put earlier warnings into a more reassuring perspective and lower dosage formulations became available, sales in developed countries substantially exceeded previous levels.